Craig Eric Schneier
Keine laufenden Positionen mehr
Karriereverlauf von Craig Eric Schneier
Ehemalige bekannte Positionen von Craig Eric Schneier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOGEN INC. | Personalreferent | 18.03.2011 | 18.03.2011 |
| Public Communications Contact | 18.03.2011 | 18.03.2011 | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Personalreferent | 01.01.2001 | 01.11.2003 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Personalreferent | 14.12.2010 | - |
| Corporate Officer/Principal | 01.01.2001 | 14.12.2010 | |
| Vertrieb & Marketing | 14.12.2010 | - |
Ausbildung von Craig Eric Schneier
| The University of Colorado | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Human Resources Officer | 3 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
- Börse
- Insiders
- Craig Eric Schneier
- Erfahrung
